These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 26356818

  • 1. RET mutation p.S891A in a Chinese family with familial medullary thyroid carcinoma and associated cutaneous amyloidosis binding OSMR variant p.G513D.
    Qi XP, Zhao JQ, Chen ZG, Cao JL, Du J, Liu NF, Li F, Sheng M, Fu E, Guo J, Jia H, Zhang YM, Ma JM.
    Oncotarget; 2015 Oct 20; 6(32):33993-4003. PubMed ID: 26356818
    [Abstract] [Full Text] [Related]

  • 2. The modifier role of RET-G691S polymorphism in hereditary medullary thyroid carcinoma: functional characterization and expression/penetrance studies.
    Colombo C, Minna E, Rizzetti MG, Romeo P, Lecis D, Persani L, Mondellini P, Pierotti MA, Greco A, Fugazzola L, Borrello MG.
    Orphanet J Rare Dis; 2015 Mar 01; 10():25. PubMed ID: 25887804
    [Abstract] [Full Text] [Related]

  • 3. The rare intracellular RET mutation p.S891A in a Chinese Han family with familial medullary thyroid carcinoma.
    Qi XP, Zhang RX, Cao JL, Chen ZG, Jin HY, Yang RR.
    J Biosci; 2014 Jun 01; 39(3):505-12. PubMed ID: 24845513
    [Abstract] [Full Text] [Related]

  • 4. Thyroid Malignancy and Cutaneous Lichen Amyloidosis: Key Points Amid RET Pathogenic Variants in Medullary Thyroid Cancer/Multiple Endocrine Neoplasia Type 2 (MEN2).
    Stanescu LS, Ghemigian A, Ciobica ML, Nistor C, Ciuche A, Radu AM, Sandru F, Carsote M.
    Int J Mol Sci; 2024 Sep 10; 25(18):. PubMed ID: 39337252
    [Abstract] [Full Text] [Related]

  • 5. Screening of RET gene mutations in Chinese patients with medullary thyroid carcinoma and their relatives.
    Wang J, Zhang B, Liu W, Zhang Y, Di X, Yang Y, Yan D.
    Fam Cancer; 2016 Jan 10; 15(1):99-104. PubMed ID: 26254625
    [Abstract] [Full Text] [Related]

  • 6. A rare RET mutation in an Indian pedigree with familial medullary thyroid carcinoma.
    Vijayan R, Nair V, Menon U, Kumar H.
    Indian J Cancer; 2021 Jan 10; 58(1):98-100. PubMed ID: 33402557
    [Abstract] [Full Text] [Related]

  • 7. Germ line mutation analysis in families with multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma.
    Karga HJ, Karayianni MK, Linos DA, Tseleni SC, Karaiskos KD, Papapetrou PD.
    Eur J Endocrinol; 1998 Oct 10; 139(4):410-5. PubMed ID: 9820617
    [Abstract] [Full Text] [Related]

  • 8. The RET mutation E768D confers a late-onset familial medullary thyroid carcinoma -- only phenotype with incomplete penetrance: implications for screening and management of carrier status.
    Dabir T, Hunter SJ, Russell CF, McCall D, Morrison PJ.
    Fam Cancer; 2006 Oct 10; 5(2):201-4. PubMed ID: 16736292
    [Abstract] [Full Text] [Related]

  • 9. Germline ESR2 mutation predisposes to medullary thyroid carcinoma and causes up-regulation of RET expression.
    Smith J, Read ML, Hoffman J, Brown R, Bradshaw B, Campbell C, Cole T, Navas JD, Eatock F, Gundara JS, Lian E, Mcmullan D, Morgan NV, Mulligan L, Morrison PJ, Robledo M, Simpson MA, Smith VE, Stewart S, Trembath RC, Sidhu S, Togneri FS, Wake NC, Wallis Y, Watkinson JC, Maher ER, McCabe CJ, Woodward ER.
    Hum Mol Genet; 2016 May 01; 25(9):1836-45. PubMed ID: 26945007
    [Abstract] [Full Text] [Related]

  • 10. Distribution of RET Mutations and Evaluation of Treatment Approaches in Hereditary Medullary Thyroid Carcinoma in Turkey.
    Aydoğan Bİ, Yüksel B, Tuna MM, Navdar Başaran M, Akkurt Kocaeli A, Ertörer ME, Aydın K, Güldiken S, Şimşek Y, Cihan Karaca Z, Yılmaz M, Aktürk M, Anaforoğlu İ, Kebapçı N, Duran C, Taşlıpınar A, Kulaksızoğlu M, Gürsoy A, Dağdelen S, Erdoğan MF.
    J Clin Res Pediatr Endocrinol; 2016 Mar 05; 8(1):13-20. PubMed ID: 26758973
    [Abstract] [Full Text] [Related]

  • 11. Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma.
    Elisei R, Bottici V, Cappagli V, Ramone T, Tacito A, Ciampi R, Romei C.
    Ann Endocrinol (Paris); 2019 Jun 05; 80(3):187-190. PubMed ID: 31053251
    [Abstract] [Full Text] [Related]

  • 12. Penetrance of inherited medullary thyroid carcinoma and genotype-phenotype correlation in a large multiple endocrine neoplasia type 2A family with C634Y RET mutation.
    González-Yebra B, Medrano ME, Mantilla A, Palma V, Colin C, Hernández DM, Tapia J, Dawson B, Salcedo M.
    Endocr Pathol; 2003 Jun 05; 14(1):71-80. PubMed ID: 12746565
    [Abstract] [Full Text] [Related]

  • 13. M918V RET mutation causes familial medullary thyroid carcinoma: study of 8 affected kindreds.
    Martins-Costa MC, Cunha LL, Lindsey SC, Camacho CP, Dotto RP, Furuzawa GK, Sousa MS, Kasamatsu TS, Kunii IS, Martins MM, Machado AL, Martins JR, Dias-da-Silva MR, Maciel RM.
    Endocr Relat Cancer; 2016 Dec 05; 23(12):909-920. PubMed ID: 27807060
    [Abstract] [Full Text] [Related]

  • 14. The Clinical Spectrum of Multiple Endocrine Neoplasia Type 2A with Cutaneous Lichen Amyloidosis in Ethnic Han Chinese.
    Qi XP, Zhao JQ, Cao ZL, Fu E, Li F, Zhao YH, Wang GP, Li PF, Ma WL, Guo J, Jia H.
    Cancer Invest; 2018 Feb 07; 36(2):141-151. PubMed ID: 29420094
    [Abstract] [Full Text] [Related]

  • 15. RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center.
    Elisei R, Romei C, Cosci B, Agate L, Bottici V, Molinaro E, Sculli M, Miccoli P, Basolo F, Grasso L, Pacini F, Pinchera A.
    J Clin Endocrinol Metab; 2007 Dec 07; 92(12):4725-9. PubMed ID: 17895320
    [Abstract] [Full Text] [Related]

  • 16. A novel germline variant in RET gene resulting in an additional cysteine in a family with familial medullary thyroid carcinoma.
    Oriola J, Sanchez A, Paniello B, de la Bellacasa JP, Biarnés J.
    Fam Cancer; 2021 Jul 07; 20(3):253-256. PubMed ID: 33084974
    [Abstract] [Full Text] [Related]

  • 17. RET germline mutations identified by exome sequencing in a Chinese multiple endocrine neoplasia type 2A/familial medullary thyroid carcinoma family.
    Qi XP, Ma JM, Du ZF, Ying RB, Fei J, Jin HY, Han JS, Wang JQ, Chen XL, Chen CY, Liu WT, Lu JJ, Zhang JG, Zhang XN.
    PLoS One; 2011 Jul 07; 6(5):e20353. PubMed ID: 21655256
    [Abstract] [Full Text] [Related]

  • 18. All in the family? Analyzing the impact of family history in addition to genotype on medullary thyroid carcinoma aggressiveness in MEN2A patients.
    Long KL, Etzel C, Rich T, Hyde S, Perrier ND, Graham PH, Lee JE, Hu MI, Cote GJ, Gagel R, Grubbs EG.
    Fam Cancer; 2017 Apr 07; 16(2):283-289. PubMed ID: 27864651
    [Abstract] [Full Text] [Related]

  • 19. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
    Prazeres HJ, Rodrigues F, Figueiredo P, Naidenov P, Soares P, Bugalho MJ, Lacerda M, Campos B, Martins TC.
    Clin Endocrinol (Oxf); 2006 Jun 07; 64(6):659-66. PubMed ID: 16712668
    [Abstract] [Full Text] [Related]

  • 20. [Familial medullary thyroid carcinoma: case report and literature review.].
    Barletta Carrillo CF, Poterico Rojas JA, Barrionuevo Cornejo C, Casavilca Zambrano S, Pinedo Cárdenas A, Quispe Santibañez I, Castro Mujica MDC.
    Rev Fac Cien Med Univ Nac Cordoba; 2018 Dec 12; 75(4):303-309. PubMed ID: 30734711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.